Sun SY - Search Results

1

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: sun sy. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

2

Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.

Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R. Sun SY, et al. Cancer Res. 1997 Nov 1;57(21):4931-9. Cancer Res. 1997. PMID: 9354460

3

Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.

Sun SY, Yue P, Hong WK, Lotan R. Sun SY, et al. Cancer Res. 2000 Nov 15;60(22):6537-43. Cancer Res. 2000. PMID: 11103825

4

c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.

Zou W, Liu X, Yue P, Zhou Z, Sporn MB, Lotan R, Khuri FR, Sun SY. Zou W, et al. Among authors: sun sy. Cancer Res. 2004 Oct 15;64(20):7570-8. doi: 10.1158/0008-5472.CAN-04-1238. Cancer Res. 2004. PMID: 15492284

5

Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.

Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Liu X, et al. Among authors: sun sy. J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322. J Natl Cancer Inst. 2004. PMID: 15572759

6

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. Sun SY, et al. Cancer Res. 2005 Aug 15;65(16):7052-8. doi: 10.1158/0008-5472.CAN-05-0917. Cancer Res. 2005. PMID: 16103051

7

Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.

Zhang X, Chen ZG, Choe MS, Lin Y, Sun SY, Wieand HS, Shin HJ, Chen A, Khuri FR, Shin DM. Zhang X, et al. Among authors: sun sy. Clin Cancer Res. 2005 Sep 1;11(17):6261-9. doi: 10.1158/1078-0432.CCR-04-2102. Clin Cancer Res. 2005. PMID: 16144930

8

LKB1 mutation in large cell carcinoma of the lung.

Zhong D, Guo L, de Aguirre I, Liu X, Lamb N, Sun SY, Gal AA, Vertino PM, Zhou W. Zhong D, et al. Among authors: sun sy. Lung Cancer. 2006 Sep;53(3):285-94. doi: 10.1016/j.lungcan.2006.05.018. Epub 2006 Jul 5. Lung Cancer. 2006. PMID: 16822578

9

Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.

Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY. Liu X, et al. Among authors: sun sy. Cancer Res. 2006 Dec 1;66(23):11115-9. doi: 10.1158/0008-5472.CAN-06-2471. Cancer Res. 2006. PMID: 17145853

10

PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.

Zou W, Liu X, Yue P, Khuri FR, Sun SY. Zou W, et al. Among authors: sun sy. Cancer Biol Ther. 2007 Jan;6(1):99-106. doi: 10.4161/cbt.6.1.3555. Cancer Biol Ther. 2007. PMID: 17172826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters